GPCR
Structure Therapeutics Inc. American Depositary Shares
Nasdaq · usd
Structure Therapeutics Inc. American Depositary Shares (GPCR) trades at $16.13 (-5.78%) as of 7:30:06 PM EST on Nov 20, 2026, -26.45% over the past month. Market cap is $1.15B, with 6.5 days to cover in short interest.
Stock performance
How Structure Therapeutics Inc. American Depositary Shares (GPCR) stock has performed from one day to one year, with its 52-week range.
- 1D
- -5.78%
- 1W
- -19.35%
- 1M
- -26.45%
- YTD
- -76.81%
- 1Y
- -54.31%
- 52-wk range
- $16.06 – $94.90
Key statistics
Today's trading snapshot for GPCR: day range, open, previous close, volume and market cap.
- Day range
- $16.06 – $17.08
- Open
- $16.73
- Prev close
- $17.12
- Volume
- 786.24K
- Market cap
- $1.15B
- Shares out
- 70.03M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Structure Therapeutics Inc. American Depositary Shares: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 1.00
- P/FCF
- —
- ROE
- -24.1%
- ROA
- -22.0%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 19, 2026
8-K filings
Material corporate events Structure Therapeutics Inc. American Depositary Shares has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 9, 2026
On November 9, 2026, Structure Therapeutics Inc. (the "Company") issued a press release providing a corporate update and announcing its financial results for the third quarter ended September 30, 2026.
- Clinical trial resultsSep 8, 2026
Aleniglipron's safety and tolerability profile remained consistent through 72 weeks. Treatment discontinuations due to TEAEs occurred in fewer than 5% of participants in the OLE.
- Annual meeting resultsJun 18, 2026
On June 17, 2026, Structure Therapeutics Inc. held its 2026 Annual General Meeting of Shareholders. Ted W. Love M.D., Raymond Stevens, Ph.D. and Daniel G. Welch were elected as a Class III directors with voting results showing 164,241,780 votes for Ted W. Love, 164,373,741 votes for Raymond Stevens, and 161,336,058 votes for Daniel G. Welch.
- Underwriting agreementMay 7, 2026
On May 7, 2026, Structure Therapeutics Inc. (the "Company") amended and restated that certain Sales Agreement dated August 6, 2025 (the "Sales Agreement" and as amended and restated, the "Amended and Restated Sales Agreement") with Leerink Partners LLC and Cantor Fitzgerald & Co. (collectively, the "Sales Agents"), relating to the offer and sale of the Company's American Depositary Shares ("ADSs").
- Executive compensation changeApr 15, 2026
Pursuant to the terms of Mr. Lang's employment agreement, effective as of April 15, 2026, Mr. Lang will receive a base salary of $560,000 per year and be eligible for an annual discretionary bonus with a target amount of 40% of his base salary. Mr. Lang will be granted (i) an option to purchase 223,776 ordinary shares (representing 74,592 American Depositary Shares ("ADSs")), (ii) a time-based restricted share unit award (the "RSUs") in respect of 184,614 ordinary shares (representing 61,538 ADSs) and (iii) a performance-based restricted share unit award (the "PSUs") in respect of 46,155 ordinary shares (representing 15,385 ADSs) at target levels.
GPCR short interest
How heavily GPCR is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 6.5
- Short interest
- 5.93M
- Avg volume
- 911.82K
As of · reported to FINRA twice monthly.
GPCR news
The latest news and headlines about Structure Therapeutics Inc. American Depositary Shares (GPCR).
- Will Wegovy Pill Drive Renewed GLP-1 Growth Momentum for Novo Stock?positiveZacks Investment Research· Nov 11, 2026
- Novo Up 4% in a Month: How Should Investors Approach the Stock Now?neutralZacks Investment Research· Nov 9, 2026
- Novo Before Q3 Earnings: How Should Investors Play the Stock?negativeZacks Investment Research· Nov 2, 2026
- How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?neutralZacks Investment Research· Oct 21, 2026
- How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?positiveZacks Investment Research· Oct 19, 2026
Frequently asked questions
What is the Structure Therapeutics Inc. American Depositary Shares (GPCR) stock price today?
Structure Therapeutics Inc. American Depositary Shares (GPCR) is trading at $16.13 (-5.78% on the day) as of 7:30:06 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Structure Therapeutics Inc. American Depositary Shares?
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs.
What is the short interest in GPCR?
As of Oct 30, 2026, GPCR has 5.93M shares short and 6.5 days to cover.
What exchange is GPCR listed on?
Structure Therapeutics Inc. American Depositary Shares (GPCR) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of GPCR with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a GPCR analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.